INMUNE BIO INC. Capital Expenditures
INMUNE BIO INC. (INMB) reported Capital Expenditures of $1.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-30
- INMUNE BIO INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $143.00K.
- INMUNE BIO INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $193.00K.
- INMUNE BIO INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.04M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $336.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.04M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $899.00K 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | $706.00K 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |